SCHEMBL3846719

SCHEMBL3846719

COc1cccc(-c2cnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cn23)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.46
TGFBR1 P36897 10/20 0.44
TGFBR2 P37173 1/20 0.42
CSNK1D P48730 4/20 0.41
CSNK1E P49674 4/20 0.41
IRAK4 Q9NWZ3 2/20 0.40
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA3 P34903 1/20 0.39
DYRK3 O43781 1/20 0.36
CCNT1 O60563 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CDK9 P50750 1/20 0.36
CDK5 Q00535 1/20 0.36
DYRK1A Q13627 1/20 0.36
CDK5R1 Q15078 1/20 0.36
DYRK2 Q92630 1/20 0.36
DYRK1B Q9Y463 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849706 0.86 FLT3 (0.46) CDK2DYRK1AFLT3
SCHEMBL3847481 0.86 TGFBR1 (0.40) TGFBR1TGFBR2CSNK1DCSNK1EFLT3
SCHEMBL3846723 0.85 KDR (0.39) KDRTGFBR1TGFBR2CSNK1DCSNK1E
SCHEMBL3854603 0.84 EIF2AK4 (0.46) TGFBR1CSNK1DCSNK1EIRAK4FLT3
SCHEMBL3846497 0.83 FYN (0.41) FLT3
SCHEMBL6644463 0.82 MAPK14 (0.41) TGFBR1CSNK1DCSNK1EFLT3
SCHEMBL3849253 0.82 FLT3 (0.38) TGFBR1DYRK3CCNT1CCNA2CDK2
SCHEMBL3848318 0.82 IRAK4 (0.44) KDRTGFBR1TGFBR2IRAK4DYRK3
SCHEMBL3845287 0.82 IRAK4 (0.44) KDRTGFBR1TGFBR2IRAK4DYRK3
SCHEMBL3845245 0.82 FLT3 (0.39) TGFBR1TGFBR2CSNK1DCSNK1EFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed